Searched for
CIPLA TRUMP
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Ahead of Market: 10 things that will decide stock market action on ThursdayNifty 50 and BSE Sensex declined, snapping a three-day rally due to IT and FMCG losses. Rising India VIX signaled caution, though broader t...
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
- Sun Pharma, Wockhardt & other pharma stocks crack up to 9% as Trump announces 100% tariff on imported patented drugsPharma stocks declined following Donald Trump's tariff announcement. Wockhardt experienced the biggest drop. Sun Pharma also hit a 52-week ...
- Sun Pharma, Cipla or Dr Reddy's: Which pharma major is most vulnerable to Trump's 100% tariffPresident Trump's imposition of 100% tariffs on branded drugs has shaken Indian pharma companies, impacting stocks like Sun Pharma, Cipla, ...
- Explained: What Dr Trump’s 100% bitter tariff pill means for India’s $10 billion pharma export machineThe US has imposed a 100% tariff on branded and patented pharmaceuticals, targeting imports from India’s $10 billion export industry. While...
- Pharma stocks in focus as Trump warns tariffs could hit 250%Pharma stocks such as Sun Pharma, Cipla, Dr Reddy’s Laboratories, Lupin, and others will be in focus on Wednesday after US President Donald...
- Pharma exporters expect Trump to act benevolently to themIndian drug makers, heavily reliant on the US market, face potential challenges due to President Trump's proposed 25% reciprocal tariff on ...
- Dr Reddy’s, Sun Pharma and other pharma stocks fall up to 3% as Trump threatens 25% tariff on IndiaIndian pharma stocks fell up to 3% after U.S. President Trump announced a 25% tariff on Indian imports over its trade with Russia. Concerns...
- Donald Trump’s order to lower prices may benefit generics, says Cipla CEOCipla anticipates that Donald Trump's order to lower US drug prices could favor generic drug companies like itself. The company reported a ...
- Pharma shares slip up to 3% as Trump order to boost U.S. drug manufacturing rattles Indian exportersIndian pharmaceutical stocks experienced a significant decline. This followed US President Donald Trump's executive order. The order aims t...
- Now Pharma Inc looks for cure as Trump delivers dose of anxietyUS President Trump has announced that new tariffs on pharmaceuticals will be introduced soon, creating uncertainty for India's drug makers....
- Tariffs should not dictate how Indian drugmakers do business, Cipla CEO saysTariffs should not drive decisions at Indian drug companies despite potential U.S. import taxes, warns Cipla's CEO, as Trump suggests dutie...
- Dr. Reddy’s shares fall 6%, Aurobindo Pharma 10% as Trump signals 25% tariffs on pharma importsDr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest drugmaker, declined b...
- US Tariffs on pharma: What are the potential impact on Indian drugmakersUS tariffs on pharmaceutical imports will affect India’s pharma sector, a leader in affordable generics. Analyst Vishal Manchanda highlight...
- Cipla sees no major impact on biz from Donald Trump admin's decision to pause foreign aid: Umang VohraCipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the Trump adminis...
- Pharma stocks underperformed during Trump's first term. Will second term change the narrative?During Trump’s 2017-2021 tenure, Indian pharma equities faced challenges, including increased FDA regulatory actions that raised compliance...
- Torrent in top gear to close out Cipla buyout, in talks with PEs, banks for fundsRival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among othe...
- These are the companies manufacturing COVID-19 drug Remdesivir in India
- Mapping the market: Look who all gained when market shrugged off border turmoilLiquor stocks soared up to 20 per cent after the Supreme Court dismissed a BJP leader’s plea seeking a complete ban on liquor across India.
Load More
